Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes

scientific article

Medicare part D's exclusion of benzodiazepines and fracture risk in nursing homes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHINTERNMED.2010.57
P932PMC publication ID2907144
P698PubMed publication ID20421554
P5875ResearchGate publication ID43345759

P50authorStephen B SoumeraiQ92319331
Becky A. BriesacherQ124500076
Terry S FieldQ91395522
Jerry H GurwitzQ91395531
P2093author name stringHassan Fouayzi
P2860cites workSedative hypnotics in older people with insomnia: meta-analysis of risks and benefitsQ24538295
Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signsQ28263803
Benzodiazepines and hip fractures in elderly people: case-control studyQ28361148
Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older AdultsQ30050268
Falls documentation in nursing homes: agreement between the minimum data set and chart abstractions of medical and nursing documentationQ30981444
The accuracy of Minimum Data Set diagnoses in describing recent hospitalization at acute care facilitiesQ31040528
The nursing home Minimum Data Set assessment instrument: manifest functions and unintended consequences--past, present, and futureQ33468806
Nursing home residents and enrollment in Medicare Part D.Q33946903
Risk factors for recurrent nonsyncopal falls. A prospective studyQ34522798
National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure surveyQ36059992
Managing disruptive behaviors with neuroleptics: treatment options for older adults in nursing homesQ36326954
Benzodiazepines of long and short elimination half-life and the risk of hip fractureQ38367453
A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid populationQ39695660
Falls among older people: relationship to medication use and orthostatic hypotensionQ40971505
Central nervous system active medications and risk for fractures in older womenQ44420332
The exclusion of benzodiazepine coverage in medicare: simple steps for avoiding a public health crisisQ46691430
Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture ratesQ50181300
Case-control study of exposure to medication and the risk of injurious falls requiring hospitalization among nursing home residents.Q50959124
Do drugs affect the risk of hip fracture in elderly women?Q67932610
Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawalQ68089186
Medications and diagnoses in relation to falls in a long-term care facilityQ68994202
Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study GroupQ70139861
Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residentsQ71838656
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectbone fractureQ68833
P304page(s)693-698
P577publication date2010-04-01
P1433published inJAMA Internal MedicineQ177428
P1476titleMedicare part D's exclusion of benzodiazepines and fracture risk in nursing homes
P478volume170

Reverse relations

cites work (P2860)
Q37301216A critical review of methods to evaluate the impact of FDA regulatory actions.
Q47574796Complexity of illness and adjunctive benzodiazepine use in outpatients with bipolar I or II disorder: results from the Bipolar CHOICE study
Q35291961Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users
Q54963186Effect of total exemption from medical service co-payments on potentially inappropriate medication use among elderly ambulatory patients in a single center in Japan: a retrospective cross-sectional study.
Q27023843Medicare Part D and quality of prescription medication use in older adults
Q35470790Medicare Part D benzodiazepine exclusion and use of psychotropic medication by patients with new anxiety disorders
Q38915260Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.
Q36105740Medicare Part D's effect on the under- and overuse of medications: a systematic review
Q38111298Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence
Q36165497Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance
Q33652790Medicare part d and the federal employees health benefits program: a comparison of prescription drug coverage
Q37799121Medication and Falls: Risk and Optimization
Q36913286Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents
Q44349136Prevalence of Long-Term Opioid Use in Long-Stay Nursing Home Residents
Q47908138Psychotropic medication use and association with physical and psychosocial outcomes in nursing home residents
Q44608178Uncovering the source of new benzodiazepine prescriptions in community-dwelling older adults'.
Q36398853Use of medications of questionable benefit in advanced dementia
Q84977169What Is a Geriatric Psychopharmacologist to Do?

Search more.